Corporate
Profile

Failed to register as Favorite Page
Failed to cancel as Favorite Page
This page is already registered as a Favorite Page
You can't add your company to your favorites.

Latest update: 20/03/2019 09:21:32

BIOMIO. CO., LTD.

Development and sales of products containing a novel enzyme for cancer treatment

We develop and sell products containing the novel enzyme arazyme invented by the Korea Research Institute of Bioscience and Biotechnology (KRIBB). Our main products are cosmetics. Arazyme is a high-efficiency proteolytic enzyme that was invented in cancer treatment studies. It is a safe and non-toxic native enzyme with antibacterial effects. It has been subjected to studies because it is expected to be effective for cancer treatment, lifestyle-related diseases, HIV, and so on. We have obtained patents for it in 44 countries including Japan. Arazyme is also expected to be used in various fields such as medicines, agriculture and livestock, fisheries, cosmetics, supplements, and industrial applications.

Inquiry

Overview

Corporate name BIOMIO. CO., LTD.
Representative Naomi Horita
Corporate website http://www.biomio.jp
Number of Employees 2 (Number of full-time employees: 2)
Head office: Country Japan
Head office: Address 3F, 1-24, Kamitori-cho, Chuo-ku, Kumamoto-shi, Kumamoto, 860-0845
Industry Miscellaneous manufacturing industries
Inquiry